Papers
4
Total Citations
59
H-Index
4
About
Emile Rijcken is a leading surgical researcher whose work focuses on advancing minimally invasive techniques for gastrointestinal cancers and inflammatory bowel disease (IBD). His major contributions center on robotic-assisted esophagectomy (RAMIE) for esophageal cancer, where he has demonstrated that robotic approaches significantly reduce postoperative acute pain and enhance the likelihood of complete tumor removal (R0-resection) through total mesoesophageal excision. His comparative studies between hybrid and full-robotic techniques provide critical evidence for optimizing surgical safety and reducing morbidity. In IBD, Rijcken has championed the use of minimally invasive surgery to minimize operative trauma in young patients who often require multiple interventions over their lifetime. His most cited work includes a 2016 review on IBD surgery (21 citations) and a 2022 clinical trial on RAMIE and pain reduction (15 citations), with recent 2024 findings further solidifying his impact. Rijcken’s research at Muenster University has directly shaped modern surgical protocols, offering patients faster recovery and better oncologic outcomes. His work is essential reading for surgeons and researchers aiming to refine robotic and minimally invasive approaches in complex gastrointestinal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4